Passage Bio to Present at 19th Annual Needham Healthcare Conference
Passage Bio, Inc. (PASG)
Company Research
Source: GlobeNewswire
PHILADELPHIA, April 08, 2020 (GLOBE NEWSWIRE) -- Passage Bio, Inc. (NASDAQ: PASG), a genetic medicines company focused on developing transformative therapies for rare, monogenic central nervous system disorders, today announced that management will present at the virtual 19th Annual Needham Healthcare Conference on Wednesday, April 15, 2020 at 12:50pm ET. A live audio webcast of the presentation will be available on the Investors & Media section of Passage Bio’s website at investors.passagebio.com. A replay of the webcast will be available for 30 days following the presentation. About Passage Bio Passage Bio is a genetic medicines company focused on developing transformative therapies for rare, monogenic central nervous system disorders with limited or no approved treatment options. The company is based in Philadelphia, PA and has a research, collaboration and license agreement with the University of Pennsylvania and its Gene Therapy Program (GTP). The GTP conducts IND-enabling pr
Show less
Read more
Impact Snapshot
Event Time:
PASG
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
PASG alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
PASG alerts
High impacting Passage Bio, Inc. news events
Weekly update
A roundup of the hottest topics
PASG
News
- Passage Bio (PASG) had its price target lowered by Oppenheimer Holdings, Inc. from $30.00 to $15.00. They now have an "outperform" rating on the stock.MarketBeat
- Passage Bio (PASG) had its "hold" rating reaffirmed by TD Cowen.MarketBeat
- Passage Bio (PASG) had its "neutral" rating reaffirmed by Wedbush. They now have a $8.00 price target on the stock.MarketBeat
- Passage Bio (PASG) was given a new $7.00 price target by Chardan Capital.MarketBeat
- Passage Bio (PASG) was downgraded by Lucid Cap Mkts from "strong-buy" to "hold".MarketBeat
PASG
Earnings
- 11/10/25 - Beat
PASG
Sec Filings
- 4/20/26 - Form 8-K
- 4/7/26 - Form ARS
- 4/7/26 - Form DEFA14A
- PASG's page on the SEC website